Admission Date:  [**2148-10-6**]              Discharge Date:   [**2148-10-11**]  Date of Birth:  [**2077-10-26**]             Sex:   M  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**Last Name (NamePattern1) 4377**] Chief Complaint: Fever, hypotension  Major Surgical or Invasive Procedure: - Laryngoscopy   History of Present Illness: Mr. [**Known lastname 51902**] is a 70 year old man with a long history of marginal zone lymphoma s/p auto SCT [**2140**], s/p four cycles of bendamustine and Rituxan ([**7-/2148**]) but with progression of disease noted on interval PET scan, course c/b mycobacterium chelonae cutaneous infection on abdomen (recently initiated for treatment with clarithromycin with noted resolution of symptoms), recently admitted [**Date range (1) 51905**] with disease progression during which he was started on RIME (Ifosfamide, Mitoxantrone, Etoposide), also with history of kidney cancer s/p nephrectomy [**2139**]; CAD s/p CABG, bronchopulmonary aspirgillus s/p treatment with voriconazole, who presents with fevers at home in the setting of neutropenia with an outpatient sputem sample growing pansensitive pseudomonas.
He has a cough at baseline (x3 years) however this has become productive of brownish sputem over the last few weeks.
He has also noticed a sore throat for the last few days.
He received Cefepime 2g IV at [**Hospital3 **], Vancomycin 1g at [**Hospital1 18**], and Roxicet for a sore throat.
He was given a total of 3L of NS and admitted to the [**Hospital Unit Name 153**] for further workup and management.
Past Medical History: ONCOLOGIC TREATMENT HISTORY:  -  Status post eight cycles of R-CHOP chemotherapy from [**4-/2139**] to 08/[**2139**].
-  Status post left nephrectomy in [**12/2139**] with clear cell carcinoma of the kidney with stage limited to kidney only with no lymph node involvement.
-  Status post Zevalin treatment in 02/[**2140**].
-  Status post autologous stem cell transplant in 05/[**2140**].
-  Status post radiation to the right supraclavicular area following his autologous transplant.
-  Noted recurrence of his disease in [**12/2141**] with initiation of treatment on the bendamustine study, status post five cycles of therapy, which was then put on hold as of [**2142-3-27**] due to development of hemolytic anemia.
-  Status post Rituxan x 3 for noted paraspinal lesion then received XRT to the area, completed [**2143-1-2**].
-  Initiated treatment with R-CEP, first cycle given on [**2-/2143**], supported with Neulasta; the second cycle given on [**2143-3-13**] with only day one of Cytoxan and day two of VP16 due to travel; resumed cycle three of CEP on [**2143-4-10**]; cycle four of RCEP on [**2143-5-8**] with follow up CT scan showing stable disease; cycle five of RCEP on [**2143-6-5**].
Cholecystectomy and liver biopsy on [**2144-7-24**] by Dr. [**Last Name (STitle) 1924**].
Bone marrow aspirate and biopsy on [**2144-10-14**] showed a normal cellular erythroid dominant marrow with maturing trilineage hematopoiesis, although with numerous mononuclear megakaryocytes and Pelger-Huet neutrophils.
-  [**2145-1-27**], surgical replacement of aortic valve and coronary artery bypass surgery to correct coronary artery disease.
CT scan in [**8-/2145**] showed no increased adenopathy but noted large sigmoid polyp; biopsy from [**2145-9-8**] revealed non-Hodgkin lymphoma with more aggressive phenotype with Mib fraction about 70%, initiated treatment with bendamustine and Rituxan on [**2145-10-12**] and status post four cycles of therapy completed on [**2146-1-4**].
-  FDG tumor imaging on [**2145-12-6**] following three cycles of therapy showed no evidence for FDG-avid lymphoma with no adenopathy noted within the bowel in particular.
-  Status post three doses of Rituximab in [**2146-3-7**].
-  Status post right hip replacement on [**2146-4-8**].
-  Admitted to OSH for pneumonia treated with antibiotics with resolution after a period of time.
Received prolonged course of antibiotics with plan for possible sinus surgery.
-  Dose of Rituxan given on [**2147-2-22**], followed by 5 cycles of Rituxan/Bendamustine from [**2147-3-1**] to [**2147-5-31**].
Completed 5 weeks of treatment on [**2147-11-8**].
-  Sinus surgery on [**2148-2-1**], due to persistent sinus symptoms and receiving IVIG monthly due to hypogammaglobulinemia.
-  In [**3-/2148**], noted for an enlarging lymph node in the left lower cervical and supraclavicular area; PET imaging on [**2148-3-29**], showed new bilateral cervical lymph nodes, left supraclavicular lymph node peritoneal nodules and numerous musculoskeletal foci with FDG uptake consistent with recurrence.
-  Treated with a course of Rituxan from [**4-12**] to [**2148-5-3**] with no change to probable increase in supraclavicular node.
-  Initiated treatment with Bendamustine on [**5-14**] and [**2148-5-15**].
- 2nd cycle of Bendamustine and Rituxan on [**6-4**] and [**2148-6-5**].
- 3rd cycle of Bendamustine and Rituxan on [**7-2**] and [**2148-7-3**].
- 4th cycle of Bendamustine and Rituxan on [**7-23**] and [**2148-7-24**].
Other notable past medical history: - Non-Hodgkins Lymphoma (marginal zone)as above - Right hip replacement - CAD s/p AVR (bovine graft) and 3V CABG - History of hemolytic anemia - Nonalcoholic fatty liver disease - Open appendectomy - Lap cholecystectomy - Hyperlipidemia - Stage I left renal carcinoma, status post left radical nephrectomy, adrenalectomy, and regional lymphadenectomy by Dr. [**Last Name (STitle) **] in [**2139-12-7**].
- Prostate carcinoma, s/p radical prostatectomy [**2132**].
- Status post right ulnar neurolysis as management for an ulnar neuropathy by (Dr. [**Last Name (STitle) **] in [**2143-8-7**])    Social History: The patient is married and lives in [**Location **] MA.
One brother with recent stent placed.
DISCHARGE EXAM: VITALS -  Tm 98.5, Tc 98.3, 118/73, 90, 20, 98%CPAP GENERAL - comfortable, appropriate and in NAD HEENT - NC/AT, sclerae anicteric, MMM, OP clear without lesions NECK - supple LUNGS - CTAB, moving air well and symmetrically, resp unlabored, no accessory muscle use HEART - RRR, S1-S2 clear and of good quality without murmurs, rubs or gallops ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no rebound/guarding, 2cm diameter brownish scar to the right of the umbilicus NEURO - awake, A&Ox3, CNs II-XII grossly intact   Pertinent Results: ADMISSION LABS: [**2148-10-7**] 03:49AM BLOOD WBC-0.4*# RBC-2.51* Hgb-7.7* Hct-23.1* MCV-92 MCH-30.8 MCHC-33.5 RDW-14.7 Plt Ct-39* [**2148-10-7**] 03:49AM BLOOD Glucose-103* UreaN-21* Creat-1.4* Na-137 K-4.2 Cl-107 HCO3-21* AnGap-13 [**2148-10-7**] 03:49AM BLOOD Calcium-7.1* Phos-2.5* Mg-1.8 [**2148-10-7**] 03:49AM BLOOD IgG-282*L IgA-7*L IgM-49 [**2148-10-6**] 04:38PM BLOOD ASPERGILLUS GALACTOMANNAN ANTIGEN-PND [**2148-10-6**] 04:38PM BLOOD B-GLUCAN-PND [**2148-10-6**] 04:38PM BLOOD B-GLUCAN-Test [**2148-10-6**] 04:38PM BLOOD ASPERGILLUS GALACTOMANNAN ANTIGEN-Test   IMAGING: CT CHEST w/o contrast [**2148-10-6**] IMPRESSION: 1.
NOTE ADDED AT ATTENDING REVIEW: I agree with the above and note that the patient has undergone bilateral fiber optic endoscopic surgery with creation of nasal anstrostomies and extensive ethmoidectomies.
DISCHARGE LABS: [**2148-10-11**] 06:00AM BLOOD WBC-11.4* RBC-2.75* Hgb-8.5* Hct-25.1* MCV-91 MCH-30.9 MCHC-33.8 RDW-15.5 Plt Ct-127* [**2148-10-11**] 06:00AM BLOOD Neuts-93* Bands-0 Lymphs-2* Monos-2 Eos-1 Baso-0 Atyps-0 Metas-0 Myelos-2* NRBC-1* [**2148-10-11**] 06:00AM BLOOD Hypochr-OCCASIONAL Anisocy-NORMAL Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-OCCASIONAL Stipple-OCCASIONAL [**2148-10-11**] 06:00AM BLOOD Plt Smr-LOW Plt Ct-127* [**2148-10-6**] 02:56PM BLOOD Thrombn-15.1 [**2148-10-11**] 06:00AM BLOOD Glucose-104* UreaN-16 Creat-1.3* Na-140 K-4.3 Cl-106 HCO3-25 AnGap-13 [**2148-10-11**] 06:00AM BLOOD ALT-103* AST-52* LD(LDH)-393* AlkPhos-137* TotBili-0.3 [**2148-10-11**] 06:00AM BLOOD Calcium-7.9* Phos-3.4 Mg-1.9   Brief Hospital Course: Brief Course: Mr. [**Known lastname 51902**] is a 70M marginal zone lymphoma s/p SCT and now s/p 4 cycles of BR with recent admission for disease progression now on RIME admitted with neutropenic septic shock with concern for pseudomonal vs. fungal PNA.
No clear e/o PNA on CXR however possible retrocardiac process.
He was placed on Cefepime and Vancomycin.
Considered fungal coverage and sent off beta-glucan and galactomannan per ID recs (both were negative).
He was started on nystatin and anti-fungal coverage was added with micafungin.
He was transitioned to ciprofloxacin for 14 additional days.
He was discharged on nystatin for  # Wound Infection:  Abdominal would infected with M chelonae.
He was continued on clarithromycin per ID recs.
He was given an IVIg transfusion, which was not well tolerated.
Approximately half-way through the infusion he developed rigors, which were treated with demerol, benadryl, and tylenol, and stopping the infusion.
Additionally, he was continued on valcyclovir & bactrim for prophylaxis.
He was continued on neupogen until he was no longer pancytopenic.
CHRONIC ISSUES: # Chronic renal insufficiency: Baseline creatinine ~1.5 with one kidney.
The patient has a history of stage I left renal carcinoma, status post left radical nephrectomy, adrenalectomy, and regional lymphadenectomy by Dr. [**Last Name (STitle) **] in [**2139-12-7**].
# CAD s/p AVR (bovine graft) and 3V CABG: No acitive issues on this admission.
He was maintained on aspirin and statin during this admission.
TRANSITIONAL ISSUES: - HgbA1C was elevated to 6.9 - Blood cultures from [**10-9**] pending  Medications on Admission: Preadmission medications listed are correct and complete.
Albuterol-Ipratropium [**1-8**] PUFF IH [**Hospital1 **] shortness of breath 2.
Clarithromycin 500 mg PO Q12H 3.
Docusate Sodium 100 mg PO BID:PRN constipation 4.
Fluticasone Propionate NASAL 1 SPRY NU QHS 5.
FoLIC Acid 1600 mcg PO DAILY 6.
Gabapentin 300 mg PO QAM 7.
Gabapentin 600 mg PO QPM 8.
Latanoprost 0.005% Ophth.
Multivitamins 1 TAB PO DAILY 10.
Polyethylene Glycol 17 g PO DAILY:PRN constipation 11.
ValACYclovir 500 mg PO Q12H 12.
Rosuvastatin Calcium 20 mg PO DAILY 13.
Filgrastim 480 mcg SC Q24H Duration: 14 Days 14.
Aspirin 81 mg PO DAILY 15.
Levothyroxine Sodium 25 mcg PO DAILY 16.
Sulfameth/Trimethoprim DS 1 TAB PO MWF   Discharge Medications: 1.
Albuterol-Ipratropium [**1-8**] PUFF IH [**Hospital1 **] shortness of breath 2.
Clarithromycin 500 mg PO Q12H 3.
Docusate Sodium 100 mg PO BID:PRN constipation 4.
Fluticasone Propionate NASAL 1 SPRY NU QHS 5.
FoLIC Acid 1600 mcg PO DAILY 6.
Gabapentin 300 mg PO QAM 7.
Gabapentin 600 mg PO QPM 8.
Latanoprost 0.005% Ophth.
Levothyroxine Sodium 25 mcg PO DAILY 10.
Multivitamins 1 TAB PO DAILY 11.
Polyethylene Glycol 17 g PO DAILY:PRN constipation 12.
Rosuvastatin Calcium 20 mg PO DAILY 13.
Sulfameth/Trimethoprim DS 1 TAB PO MWF 14.
Miconazole Powder 2% 1 Appl TP TID Apply to axilla RX *miconazole nitrate [Anti-Fungal] 2 % 1 application three times a day Disp #*1 Bottle Refills:*0 15.
Nystatin Oral Suspension 5 mL PO TID RX *nystatin 100,000 unit/mL 5 mL by mouth three times a day Disp #*1 Bottle Refills:*0 16.
Ciprofloxacin HCl 750 mg PO Q12H RX *ciprofloxacin 750 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*17 Tablet Refills:*0 17.
Aspirin 81 mg PO DAILY 18.
ValACYclovir 500 mg PO Q12H   Discharge Disposition: Home  Discharge Diagnosis: Primary:    Sepsis with pulmonary source             Neutropenic fever             Acute on chronic renal injury             Marginal zone lymphoma             Laryngitis             Anemia  Secondary: HTN            CAD    Discharge Condition: Mental Status: Clear and coherent.
You were treated with antibiotics and IV fluids, and you improved.
Prior to leaving the ICU you underwent evaluation of your sinuses and larynx by the ENT doctors.
They saw that you have an infection in your larynx, which was also treated with antimicrobial agents.
The infusion was stopped, and your symptoms were treated with medications including benadryl, hydrocortisone and demerol.
Additionally, while you were here you were transfused a unit of packed red blood cells to treat your anemia.
Following this transfusion your hematocrit rose appropriately.
You tolerated this transfusion without any issues.
You were transitioned to an oral antibiotic (Ciprofloxacin) which you should take through [**2148-10-19**].
Followup Instructions: Department: HEMATOLOGY/BMT When: TUESDAY [**2148-10-15**] at 2:00 PM With: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 4380**], MD [**Telephone/Fax (1) 3237**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage ** You will need an EKG checked during this appointment**  Department: HEMATOLOGY/ONCOLOGY When: WEDNESDAY [**2148-10-23**] at 2:15 PM With: CHECKIN HEM ONC CC7 [**Telephone/Fax (1) 22**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage  Department: HEMATOLOGY/BMT When: WEDNESDAY [**2148-10-23**] at 3:00 PM With: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 4861**], MD [**Telephone/Fax (1) 457**] Building: SC [**Hospital Ward Name 23**] Clinical Ctr [**Location (un) **] Campus: EAST     Best Parking: [**Hospital Ward Name 23**] Garage    Completed by:[**2148-10-14**
